Testing HPV DNA in anal and cervical tumors
Treatments studied
Part of Cancer, Digestive system, Women’s health & pregnancy clinical trials.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have anal cancer (Stage I–III) or cervical cancer (Stage I–IVA)
- Your tumor test shows p16 positive (p16+) from a lab stain test
- You are planning radiation as your main (definitive) treatment, with or without other medicines
- Your cancer is linked to HPV types 16, 18, 31, 33, or 35
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a blood test to track tumor DNA in patients with HPV-related cervical or anal cancer. It aims to see if this test can detect early signs of recurrence after radiation therapy, helping guide follow-up care.
This trial tests whether adding an immunotherapy drug (retifanlimab) to standard chemoradiation improves outcomes for people with locally advanced anal cancer. The treatment is adjusted based on HPV DNA levels in your blood.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at how different types of HPV are linked to anal cancer in China. By testing your tumor sample, the researchers hope to better understand what causes anal cancer, which could help guide prevention and treatment.
This study is looking at ways to screen for anal cancer in people who are at higher risk, such as those with weakened immune systems or a history of abnormal cells in the lower genital tract. It aims to find better methods for early detection.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.